Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+574.2%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
+574.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
306.5x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202523258.15%
2024-98.52%
2023-1.03%
202275.89%
202157.16%
2020-47.87%
2019945.67%
2018-48.60%
201719736.49%
2016-58.55%